Dr Tracey Martin

(hi/ei)

2024

• Li, A. X. et al. 2024. Metastatic Lymph Node 64 (MLN64) expression in gastric cancer, the clinical and molecular implications in drug resistance. Cancer Genomics & Proteomics 21(1), pp. 30-40. (10.21873/cgp.20427)
• Li, A. X., Martin, T. A., Lane, J. and Jiang, W. G. 2024. Cellular impacts of striatins and the STRIPAK complex and their roles in the development and metastasis in clinical cancers. Cancers 16(1), article number: 76. (10.3390/cancers16010076)

2023

• Zhuang, X. et al. 2023. Expression of Claudin-9 (CLDN9) in breast cancer, the clinical significance in connection with its subcoat anchorage proteins ZO-1 and ZO-3 and impact on drug resistance. Biomedicines 11(12), article number: 3136. (10.3390/biomedicines11123136)
• Zhuang, X. et al. 2023. Claudin-10 in the blood brain barrier function of cerebral endothelial cells and transendothelial invasion of breast cancer cells. Anticancer Research 43(9), pp. 3923-3934. (10.21873/anticanres.16580)
• Frugtniet, B. A., Ruge, F., Sanders, A. J., Owen, S., Harding, K. G., Jiang, W. G. and Martin, T. A. 2023. nWASP inhibition increases wound healing via TrKb/PLCγ signalling. Biomolecules 13(2), article number: 379. (10.3390/biom13020379)
• Li, A. X. et al. 2023. Striatins and the STRIPAK complex partners in the clinical outcome of patients with breast cancer and responses to drug treatment. Chinese Journal of Cancer Research 35, pp. 365-385. (10.21147/j.issn.1000-9604.2023.04.04)

2022

• Sui, L. et al. 2022. Death associated protein-3 (DAP3) and DAP3 binding cell death enhancer-1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance. International Journal of Oncology 62(1), article number: 7. (10.3892/ijo.2022.5455)
• Gao, H., Benedikt, J., Jiang, W. and Martin, T. 2022. P-211 Claudin-16, its clinical and prognostic value in colorectal cancer. Annals of Oncology 33, pp. S324-S324. (10.1016/j.annonc.2022.04.301)
• Sui, L., Zeng, J., Ye, L., Martin, T., Jiang, W. and Hargest, R. 2022. P-282 Impact of death-associated protein-3 (DAP3) and DAP3 binding cell death enhancer 1 (DELE1) on drug sensitivity in colorectal cancer cells. Annals of Oncology 33, pp. S347. (10.1016/j.annonc.2022.04.371)
• Telford, E. A., Sanders, A. J., Owen, S., Ruge, F., Harrison, G. M., Jiang, W. G. and Martin, T. A. 2022. Hepatitis A virus cellular receptor 1 (HAVcr-1) initiates prostate cancer progression in human cells via hepatocyte growth factor (HGF)-induced changes in junctional integrity. Biomolecules 12(2), article number: 338. (10.3390/biom12020338)

2021

• Xin, L. et al. 2021. SIKs suppress tumor function and regulate drug resistance in breast cancer. American Journal of Cancer Research 11(7), pp. 3537-3557.
• Martin, T. A., Li, A. X., Sanders, A. J., Ye, L., Frewer, K., Hargest, R. and Jiang, W. G. 2021. NUPR1 and its potential role in cancer and pathological conditions (Review). International Journal of Oncology 58(5), article number: 21. (10.3892/ijo.2021.5201)
• Liu, C., Jiang, W., Zhang, L., Hargest, R. and Martin, T. A. 2021. SIPA1 Is a modulator of HGF/MET induced tumour metastasis via the regulation of tight junction-based cell to cell barrier function. Cancers 13(7), article number: 1747. (10.3390/cancers13071747)
• Gong, W., Martin, T. A., Sanders, A. J., Jiang, A., Sun, P. and Jiang, W. G. 2021. Location, function and role of stromal cell-derived factors and possible implications in cancer. International Journal of Molecular Medicine 47(2), pp. 435-443. (10.3892/ijmm.2020.4811)

2020

• Gong, W., Martin, T. A., Sanders, A. J., Hargest, R., Jiang, A., Sun, P. and Jiang, W. G. 2020. Influence of anaesthetics on the production of cancer cell motogens, stromal cell-derived factor-1 and hepatocyte growth factor by fibroblasts. Oncology Letters 21(2), article number: 140. (10.3892/ol.2020.12401)
• Liu, C., Jiang, W., Hargest, R. and Martin, T. 2020. The role of SIPA1 in the development of cancer and metastases (Review). Molecular and Clinical Oncology 13(4), article number: 32. (10.3892/mco.2020.2102)
• Cong, Y. et al. 2020. Tim-3 promotes cell aggressiveness and paclitaxel resistance through the NF-κB /STAT3 signalling pathway in breast cancer cells. Chinese Journal of Cancer Research 32(5), pp. 564-579. (10.21147/j.issn.1000-9604.2020.05.02)
• Wazir, U., Tayeh, S., Orakzai, M. A., Martin, T. A., Jiang, W. G. and Mokbel, K. 2020. Stratification using hTERT and stem cell markers confers a good prognosis in invasive breast cancer. Cancer Genomics and Proteomics 17(2), pp. 169-174. (10.21873/cgp.20177)
• Zhao, Z. et al. 2020. Abstract P3-01-18: Kinase D interacting substrate 220 (Kidins220) and disease progression of breast cancer, the role of heat shock protein90 (HSP90). Presented at: San Antonio Breast Cancer Symposium, San Antonio, TX, United States, 10-14 December 2019, Vol. 80. Vol. 4, Sup. American Association for Cancer Research pp. P3-01-18., (10.1158/1538-7445.SABCS19-P3-01-18)
• Zhao, Z. et al. 2020. Abstract P2-07-01: Kidins220 (kinase D interacting substrate 220) has a connection with neutrotrophic related factors, BDNF and NGF, in human breast cancer. Presented at: San Antonio Breast Cancer Symposium, San Antonio, TX, United States, 10-14 December 2019, Vol. 80. Vol. 4, Sup. pp. P2-07-01., (10.1158/1538-7445.SABCS19-P2-07-01)

2019

• Xu, Y., Jiang, W. -., Wang, H. -., Martin, T., Zeng, Y. -., Zhang, J. and Qi, Y. -. 2019. BDNF activates TrkB/PLCγ1 signaling pathway to promote proliferation and invasion of ovarian cancer cells through inhibition of apoptosis. European Review for Medical and Pharmacological Sciences 23(12), pp. 5093-5100. (10.26355/eurrev_201906_18173)
• Wazir, U., Orakzai, M. M. A. W., Martin, T. A., Jiang, W. G. and Mokbel, K. 2019. Correlation of TERT and stem cell markers in the context of human breast cancer. Cancer Genomics and Proteomics 16(2), pp. 121-127. (10.21873/cgp.20117)

2018

• Jia, J., Martin, T. A., Ye, L., Meng, L., Xia, N., Jiang, W. G. and Zhang, X. 2018. Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways. International Journal of Molecular Medicine 41(1), pp. 275-283. (10.3892/ijmm.2017.3224)

2017

• Xin, L., Liu, Y. H., Martin, T. A. and Jiang, W. G. 2017. The era of multigene panels comes? The clinical utility of Oncotype DX and MammaPrint. World Journal of Oncology 8(2), pp. 34-40. (10.14740/wjon1019w)
• Zhao, H., Owen, S., Davies, E. L., Jiang, W. G. and Martin, T. A. 2017. The effect of aurora kinase inhibitor on adhesion and migration in human breast cancer cells and clinical implications. World Journal of Oncology 8(5), pp. 151-161. (10.14740/wjon1062w)
• Ismail, A. F. et al. 2017. PAK5 mediates cell: cell adhesion integrity via interaction with E-cadherin in bladder cancer cells. Biochemical Journal 474(8), pp. 1333-1346. (10.1042/BCJ20160875)
• Frugtniet, B. A., Martin, T. A., Zhang, L. and Jiang, W. G. 2017. Neural Wiskott-Aldrich syndrome protein (nWASP) is implicated in human lung cancer invasion. BMC Cancer 17(1), article number: 224. (10.1186/s12885-017-3219-3)
• Yang, X. et al. 2017. A novel NHERF1 mutation in human breast cancer and effects on malignant progression. Anticancer Research 37(1), pp. 67-73. (10.21873/anticanres.11290)
• Telford, E., Jiang, W. G. and Martin, T. A. 2017. HAVcR-1 involvement in cancer progression. Histology and Histopathology 32, pp. 121-128. (10.14670/HH-11-817)
• Gu, Y. et al. 2017. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway. Oncotarget 8(5), pp. 7753-7765. (10.18632/oncotarget.13949)

2016

• Liu, R., Martin, T. A., Jordan, N., Ruge, F., Ye, L. and Jiang, W. G. 2016. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer. International Journal of Oncology 48(6), pp. 2488-2496. (10.3892/ijo.2016.3462)
• Zhao, H., Yu, H., Martin, T. A., Teng, X. and Jiang, W. G. 2016. The role of JAM-B in cancer and cancer metastasis (Review). Oncology Reports 36, pp. 3-9. (10.3892/or.2016.4773)
• Zhao, H., Yu, H., Martin, T. A., Zhang, Y., Chen, G. and Jiang, W. G. 2016. Effect of junctional adhesion molecule-2 expression on cell growth, invasion and migration in human colorectal cancer. International Journal of Oncology 48(3), pp. 929-936. (10.3892/ijo.2016.3340)
• Martin, T. A., Jordan, N., Davies, E. L. and Jiang, W. G. 2016. Metastasis to bone in human cancer is associated with loss of occludin expression. Anticancer Research 36(3), pp. 1287-1294.
• Zhao, H. et al. 2016. The clinical implications of RSK1-3 in human breast cancer. Anticancer Research 36(3), pp. 1267-1274.
• Yang, X., Si, Y., Martin, T. A. and Jiang, W. G. 2016. The impact of TIMM17A on aggressiveness of human breast cancer cells. Anticancer Research 36(3), pp. 1237-1241.
• Jia, W. et al. 2016. Expression of the Epithelial-Mesenchymal-Transition (EMT) markers, Twist, Slug, Snail, E- and N-cadherins and the association with clinical and pathological features of human pituitary adenomas [Abstract]. European Journal of Cancer 51(S3), pp. S592-S593., article number: 2925. (10.1016/S0959-8049(15)30055-1)

2015

• Liu, R., Martin, T. A., Jordan, N. J., Ruge, F., Ye, L. and Jiang, W. G. 2015. Metastasis suppressor 1 expression in human ovarian cancer: the impact on cellular migration and metastasis. International Journal of Oncology 47(4), pp. 1429-1439. (10.3892/ijo.2015.3121)
• Tan, Y., Sanders, A. J., Xie, Y., Martin, T. A., Owen, S., Ruge, F. and Jiang, W. G. 2015. Interleukin-24 (IL-24) expression and biological impact on HECV endothelial cells.. Cancer Genomics and Proteomics 12(5), pp. 243-250.
• Owen, S., Martin, T. A., Dart, D. A., Ablin, R. J., Mason, M. D. and Jiang, W. G. 2015. The prostate Transglutaminase, TGase-4, is potentially linked to the junctional proteins at tight junctions of prostate tissues and prostate cancer cells [Abstract]. European Journal of Cancer 51(S3), pp. S481., article number: 2516. (10.1016/S0959-8049(15)30048-4)
• Owen, S. et al. 2015. An investigation of Amphiphysin II transcript expression in pituitary adenomas [Abstract]. European Journal of Cancer 51(S3), pp. S580-S580., article number: 2806. (10.1016/S0959-8049(15)30053-8)
• Jiang, W. G. et al. 2015. YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells. Journal of Translational Medicine 13, article number: 280. (10.1186/s12967-015-0639-1)
• Ali, A. Y. et al. 2015. Anti-metastatic and cytotoxic properties of frankincense and scented myrrh. Anticancer Research 35(7), pp. 4310-4311.
• Martin, T. A., Jordan, N., Meyers, I. and Jiang, W. G. 2015. Comparison of blood brain barrier endothelia reveals a differential expression of tight junction proteins [Abstract]. Anticancer Research 35(7), pp. 4357-4358.
• Liu, R., Jordan, N., Martin, T. A., Ruge, F., Ye, L. and Jiang, W. G. 2015. Metastasis suppressor 1 (MTSS1) expression in human ovarian cancer; the impact on cellular migration and metastasis [Abstract]. Anticancer Research 35(7), pp. 4342-4342.
• Jia, W. et al. 2015. Association of mta-1 expression in pituitary tumours with bone invasion. Anticancer Research 35(7), pp. 4360.
• Martin, T. A. and Tiang, W. G. 2015. The blood brain barrier and the prevention of metastatic disease. Anticancer Research 35(7), pp. 4298-4299.
• Frugtniet, B., Jiang, W. G. and Martin, T. A. 2015. Investigating the effect of NWASP (Neural Wiskott-Aldrich Syndrome Protein) inhibitors on human lung cancer cell behaviour. Anticancer Research 35(7), pp. 4348-4349.
• Fang, X., Jiang, W. G. and Martin, T. A. 2015. The role of claudin-5 in the cell-cell adhesion of human keratinocytes. Anticancer Research 35(7), pp. 4367.
• Martin, T. A., Telford, E. and Jiang, W. G. 2015. HAVCR1 is a potential prognostic factor in human breast cancer. Anticancer Research 35(7), pp. 4327.
• Jia, W. et al. 2015. Expression of metastasis-associated gene-1 is associated with bone invasion and tumor stage in human pituitary adenomas. Cancer Genomics and Proteomics 12(3), pp. 113-118.
• Frugtniet, B., Jiang, W. G. and Martin, T. A. 2015. Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis. Breast Cancer: Targets and Therapy 2015(7), pp. 99-109. (10.2147/BCTT.S59006)
• Men, W., Martin, T. A., Ruge, F., Zhang, N., Du, P., Yang, Y. and Jiang, W. G. 2015. Expression of claudins in human clear cell renal cell carcinoma. Cancer Genomics and Proteomics 12(1), pp. 1-8.
• Jia, W., Zhu, J., Martin, T. A., A, J., Sanders, A. J. and Jiang, W. 2015. Epithelial-mesenchymal transition (EMT) markers in human pituitary adenomas indicate a clinical course. Anticancer Research 35(5), pp. 2635-2643.

2014

• Martin, T. A. 2014. The role of tight junctions in cancer metastasis. Seminars in Cell and Developmental Biology 36, pp. 224-231. (10.1016/j.semcdb.2014.09.008)
• Martin, T. A., Ruge, F., Harding, K. G. and Jiang, W. G. 2014. Brain-derived neurotrophic factor (bdnf) is a novel therapeutic agent in human wound healing [Abstract]. Wound Repair and Regeneration 22(5), pp. A91. (10.1111/wrr.12218)
• Ye, L., Sun, P., Sanders, A. J., Martin, T. A., Lane, J., Mason, M. D. and Jiang, W. G. 2014. Therapeutic potential of capillary morphogenesis gene 2 extracellular vWA domain in tumour-related angiogenesis. International Journal of Oncology 45(4), pp. 1565-1573. (10.3892/ijo.2014.2533)
• Martin, T. A., Mason, M. D. and Jiang, W. G. 2014. HGF and the regulation of tight junctions in human prostate cancer cells. Oncology Reports 32(1), pp. 213-224. (10.3892/or.2014.3219)
• Feng, X., Jia, S., Martin, T. A. and Jiang, W. G. 2014. Regulation and involvement in cancer and pathological conditions of MAGI1, a tight junction protein. Anticancer Research 34(7), pp. 3251-3256.
• Lane, J., Martin, T. A., Weeks, H. P. and Jiang, W. G. 2014. Structure and role of WASP and WAVE in Rho GTPase signalling in cancer. Cancer Genomics and Proteomics 11(3), pp. 155-165.
• Jia, W., Lu, R., Martin, T. A. and Jiang, W. G. 2014. The role of claudin-5 in blood-brain barrier ( BBB) and brain metastases (Review). Molecular Medicine Reports 9(3), pp. 779-785. (10.3892/mmr.2013.1875)
• Sun, T. T. et al. 2014. Disrupted interaction between CFTR and AF-6/afadin aggravates malignant phenotypes of colon cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843(3), pp. 618-628. (10.1016/j.bbamcr.2013.12.013)
• Martin, T. A. and Jiang, W. G. 2014. Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma. Oncology Reports 31(1), pp. 262-272. (10.3892/or.2013.2813)
• Frugtniet, B., Martin, T. A., Harding, K. G. and Jiang, W. G. 2014. nWASP (neural Wiskott-Aldrich syndrome protein) is a novel therapeutic target in human wound healing [Conference Abstract]. Wound Repair and Regeneration 22(5), pp. A80-A80. (10.1111/wrr.12218)
• Jia, J., Martin, T. A., Ye, L. and Jiang, W. G. 2014. FAP-alpha (Fibroblast activation protein-alpha) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway. BMC Cell Biology 15, article number: 16. (10.1186/1471-2121-15-16)

2013

• Martin, T. A., Lane, J., Harrison, G. M. and Jiang, W. G. 2013. The expression of the Nectin complex in human breast cancer and the role of Nectin-3 in the control of tight junctions during metastasis. PLoS ONE 8(12), article number: e82696. (10.1371/journal.pone.0082696)
• Yang, X., Martin, T. A. and Jiang, W. G. 2013. Biological influence of brain-derived neurotrophic factor (BDNF) on colon cancer cells. Experimental and Therapeutic Medicine 6(6), pp. 1475-1481. (10.3892/etm.2013.1330)
• Ye, L., Sun, P., Martin, T. A., Sanders, A. J., Mason, M. D. and Jiang, W. G. 2013. Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells. Urologic Oncology: Seminars and Original Investigations 31(8), pp. 1576-1583. (10.1016/j.urolonc.2012.05.006)
• Martin, T. A. and Jiang, W. G. 2013. Regulation of barrier function in human breast cancer can be controlled by the ROCK signalling pathway via interaction with SIPA-1 [Abstract]. European Journal of Cancer 49, pp. S132-S132.
• Martin, T. A., Mason, M. D. and Jiang, W. G. 2013. HGF and the regulation of tight junctions in human prostate cancer cells. European Journal of Cancer 49, pp. S132-S132.
• Wang, Y., Martin, T. A. and Jiang, W. G. 2013. HAVcR-1 expression in human colorectal cancer and its effects on colorectal cancer cells in vitro.. Anticancer Research 33(1), pp. 207-214.
• Martin, T. A., Lane, J., Ozupek, H. and Jiang, W. G. 2013. Claudin-20 promotes an aggressive phenotype in human breast cancer cells. Tissue Barriers 1(3), article number: e26518. (10.4161/tisb.26518)
• Martin, T. A., Ye, L., Sanders, A. J., Lane, J. and Jiang, W. G. 2013. Cancer invasion and metastasis: molecular and cellular perspective. In: Jandial, R. ed. Metastatic Cancer Clinical and Biological Perspectives. Austin, TX: Landes Bioscience, pp. 135-168.

2012

• Yang, X., Martin, T. A. and Jiang, W. G. 2012. Biological influence of brain-derived neurotrophic factor on breast cancer cells. International Journal of Oncology 41(4), pp. 1541-1546. (10.3892/ijo.2012.1581)
• Ji, K. et al. 2012. Expression of signal-induced proliferation-associated gene 1 (SIPA1), a rapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells. Cancer Genomics and Proteomics 9(5), pp. 321-327.
• Escudero-Esparza, A., Jiang, W. G. and Martin, T. A. 2012. Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways. Journal of Experimental & Clinical Cancer Research 31(1), pp. 43-60. (10.1186/1756-9966-31-43)
• Martin, T. A., Toms, A., Davies, L. M., Cheng, S. and Jiang, W. G. 2012. The clinical and biological implications of N-WASP expression in human colorectal cancer. Translational Gastrointestinal Cancer 1(1), pp. 10-20.
• Li, X., Martin, T. A. and Jiang, W. G. 2012. COM-1/p8 acts as a tumour growth enhancer in colorectal cancer cell lines. Anticancer Research 32(4), pp. 1229-1237.

2011

• Sanders, A. J., Martin, T. A., Ye, L., Mason, M. D. and Jiang, W. G. 2011. EPLIN is a negative regulator of prostate cancer growth and invasion. The Journal of Urology 186(1), pp. 295-301. (10.1016/j.juro.2011.03.038)
• Martin, T. A., Harrison, G. M., Mason, M. D. and Jiang, W. G. 2011. HAVcR-1 reduces the integrity of human endothelial tight junctions. Anticancer Research 31(2), pp. 467-473.
• Cheng, S., Martin, T. A., Teng, X. and Jiang, W. G. 2011. Putative breast tumor suppressor TACC2 suppresses the aggressiveness of breast cancer cells through a PLCγ pathway. Current Signal Transduction Therapy 6(1), pp. 55-64. (10.2174/157436211794109361)
• Martin, T. A., Mason, M. D. and Jiang, W. G. 2011. Hepatocyte growth factor signalling in cancer metastasis. Current Signal Transduction Therapy 6(2), pp. 180-190. (10.2174/157436211795659991)
• Lane, J., Martin, T. A. and Jiang, W. G. 2011. HGF and rhoGTPases in cancer cell motility. Current Signal Transduction Therapy 6(2), pp. 173-179. (10.2174/157436211795660052)
• Escudero-Esparza, A., Jiang, W. G. and Martin, T. A. 2011. Claudin-5 participates in the regulation of endothelial cell motility. Molecular and Cellular Biochemistry 362(1-2), pp. 71-85. (10.1007/s11010-011-1129-2)
• Martin, T. A., Mason, M. D. and Jiang, W. G. 2011. Tight junctions in cancer metastasis. Frontiers in Bioscience 16(3), pp. 898-936. (10.2741/3726)
• Escudero-Esparza, A., Jiang, W. G. and Martin, T. A. 2011. The Claudin family and its role in cancer and metastasis. Frontiers in Bioscience 16(3), pp. 1069-1083. (10.2741/3736)
• Mustafa, N., Martin, T. A. and Jiang, W. G. 2011. Metastasis tumour suppressor-1 and the aggressiveness of prostate cancer cells. Experimental and Therapeutic Medicine 2(1), pp. 157-162. (10.3892/etm.2010.184)
• Minhas, U., Martin, T. A., Ruge, F., Harding, K. G. and Jiang, W. G. 2011. Pattern of expression of CCN family members Cyr61, CTGF and NOV in human acute and chronic wounds. Experimental and Therapeutic Medicine 2(4), pp. 641-645. (10.3892/etm.2011.256)
• Awsare, N. S., Martin, T. A., Haynes, M. D., Matthews, P. N. and Jiang, W. G. 2011. Claudin-11 decreases the invasiveness of bladder cancer cells. Oncology Reports 25(6), pp. 1503-1509. (10.3892/or.2011.1244)

2010

• Lane, J., Martin, T. A. and Jiang, W. G. 2010. Targeting RhoC by way of ribozyme trangene in human breast cancer cells and its impact on cancer invasion. World Journal of Oncology 1(1), pp. 7-13. (10.4021/wjon2010.01.1202)
• Lane, J., Martin, T., McGuigan, C., Mason, M. and Jiang, W. 2010. The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy. Journal of Experimental Therapeutics and Oncology 8(3), pp. 203-210.
• Martin, T. A. and Jiang, W. G. 2010. Hepatocyte growth factor and cMET, new development in cancer therapies [Editorial]. Anti-Cancer Agents in Medicinal Chemistry 10(1), pp. 1.
• Martin, T. A. and Jiang, W. G. 2010. Hepatocyte growth factor and its receptor signalling complex as targets in cancer therapy. Anti-Cancer Agents in Medicinal Chemistry 10(1), pp. 2-6.
• Martin, T. A., Mansel, R. E. and Jiang, W. G. 2010. Loss of occludin leads to the progression of human breast cancer. International Journal of Molecular Medicine 26(5), pp. 723-734. (10.3892/ijmm_00000519)
• Herman, F., Martin, T. A., Douglas-Jones, A., Kynaston, H. G., Mansel, R. E. and Jiang, W. G. 2010. Expression of the ERM family members (ezrin, radixin and moesin) in breast cancer. Experimental and Therapeutic Medicine 1(1), pp. 153-160. (10.3892/etm_00000025)
• Escudero-Esparza, A., Martin, T. A., Douglas-Jones, A., Mansel, R. E. and Jiang, W. G. 2010. PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance. Oncology Reports 23(2), pp. 537-544. (10.3892/or_00000667)

2009

• Martin, T. A. and Jiang, W. G. 2009. Loss of tight junction barrier function and its role in cancer metastasis. Biochimica et Biophysica Acta (BBA) - Biomembranes 1788(4), pp. 872-891. (10.1016/j.bbamem.2008.11.005)
• Minhas, U., Martin, T. A., Price, P. E., Harding, K. G. and Jiang, W. G. 2009. CCN family proteins in wound healing - a pivotal role? [Abstract]. Wound Repair and Regeneration 17(4), pp. A74. (10.1111/j.1524-475X.2009.00519.x)
• Escudero-Esparza, A., Martin, T. A., Davies, M. L. and Jiang, W. G. 2009. PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance. Cancer Genomics and Proteomics 6(4), pp. 239-246.

2008

• Lane, J., Martin, T. A., Mansel, R. E. and Jiang, W. G. 2008. The expression and prognostic value of the guanine nucleotide exchange factors (GEFs) Trio, Vav1 and TIAM-1 in human breast cancer. International Seminars in Surgical Oncology 5(1), article number: 23. (10.1186/1477-7800-5-23)
• Jiang, W. G., Martin, T. A., Lewis-Russell, J. M., Douglas-Jones, A. G., Ye, L. and Mansel, R. E. 2008. Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Molecular Cancer 7, article number: 71. (10.1186/1476-4598-7-71)
• Martin, T. A., Harrison, G. M., Watkins, G. and Jiang, W. G. 2008. Claudin-16 reduces the aggressive behavior of human breast cancer cells. Journal of Cellular Biochemistry 105(1), pp. 41-52. (10.1002/jcb.21797)
• Sanders, A. J., Parr, C., Martin, T. A., Lane, J., Mason, M. D. and Jiang, W. G. 2008. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation. Journal of Cellular Physiology 216(3), pp. 780-789. (10.1002/jcp.21460)
• Lane, J., Martin, T. A., Watkins, G., Mansel, R. E. and Jiang, W. G. 2008. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. International Journal of Oncology 33(3), pp. 585-593. (10.3892/ijo_00000044)
• Davies, G., Martin, T. A., Ye, L., Lewis-Russell, J. M., Mason, M. D. and Jiang, W. G. 2008. Phospholipase-C gamma-1 (PLCγ-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells. Urologic Oncology: Seminars and Original Investigations 26(4), pp. 386-391. (10.1016/j.urolonc.2007.06.003)
• Goyal, A., Martin, T. A., Mansel, R. E. and Jiang, W. G. 2008. Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome. World Journal of Surgical Oncology 6, pp. 56-61. (10.1186/1477-7819-6-56)

2007

• Parr, C. et al. 2007. Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients. Clinical Cancer Research 13(12), pp. 3568-3576. (10.1158/1078-0432.CCR-06-2357)
• Martin, T. A., Pereira, G., Watkins, G., Mansel, R. E. and Jiang, W. G. 2007. N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer. Clinical & Experimental Metastasis 25(2), pp. 97-108. (10.1007/s10585-007-9120-8)

2006

• Lane, J., Martin, T. A. and Jiang, W. G. 2006. Novel protein binding partners for Rho-associated serine-threonine protein kinases (ROCKS) in breast cancer cells [Abstract]. Breast Cancer Research and Treatment 100(1 Supp), pp. S298-S298., article number: 6127.
• Jiang, W. G., Davies, G., Martin, T. A., Kynaston, H., Mason, M. D. and Fodstad, O. 2006. Com-1/p8 acts as a putative tumour suppressor in prostate cancer. International Journal of Molecular Medicine 18(5), pp. 981-986.
• Harrison, G., Davies, G., Martin, T. A., Mason, M. D. and Jiang, W. G. 2006. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells. Oncology Reports 15(1), pp. 199-206. (10.3892/or.15.1.199)
• Sanders, A. J., Parr, C., Davies, G., Martin, T. A., Lane, J., Mason, M. D. and Jiang, W. G. 2006. Genetic reduction of matriptase-1 expressionj is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeautics and Oncology 6(1), pp. 39-48.
• Sanders, A. J., Parr, C., Davies, G., Martin, T. A., Lane, J., Mason, M. D. and Jiang, W. G. 2006. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeutics and Oncology 6(1), pp. 39-48.

2005

• Lane, J., Martin, T. and Jiang, W. G. 2005. Targeting Rho-C by way of ribozyme transgene in human breast cancer cells and its impact on cancer invasion. Breast Cancer Research and Treatment 94(1), pp. S188-S189., article number: 4068. (10.1007/s10549-005-1234-6)
• Lane, J., Martin, T. A. and Jiang, W. G. 2005. ROCK inhibitor Y-27632 suppresses the effect of HGF in human breast cancer cells [Abstract]. Breast Cancer Research and Treatment 94(1 Supp), pp. S193-S194., article number: 4082.
• Jiang, W. G. et al. 2005. Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clinical Cancer Research 11(16), pp. 6012-6019. (10.1158/1078-0432.CCR-05-0275)
• Martin, T. A., Watkins, G., Lane, J. and Jiang, W. G. 2005. Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin. Histopathology 46(4), pp. 422-430. (10.1111/j.1365-2559.2005.02104.x)
• Martin, T. A., Goyal, A., Watkins, G. and Jiang, W. G. 2005. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Annals of Surgical Oncology 12(6), pp. 488-496. (10.1245/ASO.2005.04.010)
• Jiang, W., Davies, G., Martin, T. A., Parr, C., Mason, M. D. and Mansel, R. E. 2005. Manipulation of expression of MMP-14 and its impact on the invasivess and progression of breast cancer cells [Abstract]. Breast Cancer Research and Treatment 94, pp. S187-S187.

2003

• Jiang, W. G. et al. 2003. Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET. Clinical Cancer Research 9(11), pp. 4274-4281.
• Davies, G. et al. 2003. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesisin vivo. International Journal of Cancer 106(3), pp. 348-354. (10.1002/ijc.11220)
• Martin, T. A. et al. 2003. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis 24(8), pp. 1317-1323. (10.1093/carcin/bgg072)

2001

• Jiang, W. G., Grimshaw, A. D., Lane, J., Martin, T. A., Abounader, R., Laterra, J. and Mansel, R. E. 2001. A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. Clinical Cancer Research 7, pp. 2555-2562.
• Martin, T. A., Mansel, R. E. and Jiang, W. G. 2001. Hepatocyte growth factor modulates vascular endothelial-cadherin expresssion in human endothelial cells. Clinical Cancer Research 7(3), pp. 734-737.
• Martin, T. A. and Jiang, W. G. 2001. Tight junctions and their role in cancer metastasis.. Histology and Histopathology 16, pp. 1183-1195.
• Martin, T. A., Harding, K. G. and Jiang, W. G. 2001. Matrix-bound fibroblasts regulate angiogenesis by modulation of VE-cadherin. European Journal of Clinical Investigation 31(11), pp. 931-938. (10.1046/j.1365-2362.2001.00914.x)

1999

• Jiang, W. G., Hiscox, S. E., Parr, C., Martin, T. A., Matsumoto, K., Nakamura, T. and Mansel, R. E. 1999. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clinical Cancer Research 5(11), pp. 3695-3703.
• Jiang, W. G., Martin, T. A., Matsumoto, K., Nakamur, T. and Mansel, R. E. 1999. Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells.. Journal of Cellular Physiology 181(2), pp. 219-329. (10.1002/(SICI)1097-4652(199911)181:2<319::AID-JCP14>3.0.CO;2-S)